Johnson & Johnson announces Phase 3 ASTRO study met primary endpoints
Johnson & Johnson announced data from the Phase 3 ASTRO study of TREMFYA subcutaneous, SC, induction therapy in adults with moderately to ...
Barron's19h
Barron’s Stock Picks
Here is how the Barron’s Roundtable members’ picks performed. Find investment ideas for your portfolio with the latest stock picks from Barron’s below. These picks are the product of the ...